Sanjeeva Srivastava

This paper expands structural surfaceomics to identify cancer-specific protein conformations across multiple tumor models, revealing potential immunotherapy targets through crosslinking mass spectrometry and structural modeling.

The paper introduces DrugProtAI, a tool that predicts druggability of proteins and evaluates 20,273 human proteins, achieving a median AUC of 0.86 in target predictions.

This study identifies ECM proteins as key players in Labeo rohita's immune response to Aeromonas hydrophila infection through proteomic analysis of gut tissue.

BrainProt 3.0 integrates multi-omics data to provide a resource for understanding human brain diseases and identifying therapeutic strategies.

The paper uses proteomic analysis to identify changes in the host liver proteome during Aeromonas hydrophila infection in Labeo rohita, revealing dysregulated metabolic and immune pathways.